BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35538027)

  • 1. RP5-1148A21.3 (lncRP5) exerts oncogenic function in human ovarian carcinoma.
    Sun P; Bao A; Hua X; Cao J; Ding Y
    Acta Biochim Biophys Sin (Shanghai); 2022 Feb; 54(2):209-219. PubMed ID: 35538027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z; Kun W; Xiaochun S; Lingling T
    Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoting action of long non-coding RNA small nucleolar RNA host gene 4 in ovarian cancer.
    Liu C; Zhao S; Lv ZX; Zhao XJ
    Acta Biochim Pol; 2023 Jan; 70(1):59-68. PubMed ID: 36657061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis.
    Xu H; Wang L; Jiang X
    Mol Cell Biochem; 2021 Feb; 476(2):1051-1061. PubMed ID: 33170430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
    Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
    Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis.
    Qi X; Chen D; Yu W; Wang L; Liu L; Tao X
    Mol Cell Biochem; 2022 May; 477(5):1463-1475. PubMed ID: 35166984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
    Wang L; Yu M; Zhao S
    J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
    Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
    [No Abstract]   [Full Text] [Related]  

  • 11. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
    Liu B; Zhang J; Yang D
    J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
    Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
    Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
    Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA KCNQ1OT1 accelerates ovarian cancer progression via miR-125b-5p/CD147 axis.
    Chen P; Sun LS; Shen HM; Qu B
    Pathol Res Pract; 2022 Nov; 239():154135. PubMed ID: 36191448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of lncRNAHCP5/microRNA-525-5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells.
    Wang L; He M; Fu L; Jin Y
    Exp Cell Res; 2020 Sep; 394(1):112129. PubMed ID: 32511950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of long noncoding RNA XIST has anticancer effects on ovarian cancer through sponging miR-106a.
    Guo T; Yuan D; Zhang W; Zhu D; Xiao A; Mao G; Jiang W; Lin M; Wang J
    Hum Cell; 2021 Mar; 34(2):579-587. PubMed ID: 33400246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z; Gao S; Xuan L; Liu X
    J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C; Li Y; Zhao W; Liu G; Yang Q
    Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA LUCAT1 promotes proliferation of ovarian cancer cells by regulating miR-199a-5p expression.
    Liu HZ; Liu GY; Pang WW; Zhang H; Zeng ZJ; Wang HJ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1682-1687. PubMed ID: 32141534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.
    Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
    Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.